• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    Police to deploy facial recognition on CCTV networks

    Israeli fire kills five in Gaza, including a child

    Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and Enrichment Strategy for HBV Functional Cure

    A brutal sell-off for AI stocks sends Wall St reeling

    Overseas university heads eye NM

    Overseas university heads eye NM

    Cheche Group Announces Extraordinary General Meeting

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    Police to deploy facial recognition on CCTV networks

    Israeli fire kills five in Gaza, including a child

    Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and Enrichment Strategy for HBV Functional Cure

    A brutal sell-off for AI stocks sends Wall St reeling

    Overseas university heads eye NM

    Overseas university heads eye NM

    Cheche Group Announces Extraordinary General Meeting

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

Cell therapy is promising in treating psychiatric disorders, such as depression. — A proof-of-principle study published in “Cell Stem Cell” by the laboratory of Dr. Chen, founder of UniXell Biotech, suggests this.

PR Newswire by PR Newswire
20 August 2025
in PR Newswire
0
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

SHANGHAI, Aug. 20, 2025 /PRNewswire/ — On August 11, 2025, the research team led by Professor Yuejun Chen, founder of UniXell Biotech, published an article titled “Human stem cell-derived A10 dopaminergic neurons specifically integrate into mouse circuits and improve depression-like behaviors” in Cell Stem Cell, featured as a cover story. This study marks the first establishment of a technique to efficiently and directionally differentiate human pluripotent stem cells (hPSCs) into A10 subtype dopamine neurons. This breakthrough lays a critical scientific foundation for cell therapy of psychiatric disorders such as depression.

In this study, the R&D team of UniXell Biotechnology played a crucial role in manuscript preparation/cell differentiation, transplantation, and immunohistochemistry analysis/cell line establishment, driving the entire process from proof-of-concept to publication and providing key support for the high-quality presentation of the research outcomes. 

Depression is one of the most common mental disorders in the 21st century, projected to become one of the top three causes of global disease burden by 2030. Despite the widespread clinical use of existing antidepressant drugs, approximately one-third of patients suffer from treatment-resistant depression (TRD), showing poor response to current pharmacotherapies. The fundamental symptoms exhibited by depression patients, such as anhedonia and anxiety disorders, are closely associated with the regulatory network of A10 dopaminergic neuron subtypes.

The authors found that whether hPSC-derived A10 dopaminergic neurons were transplanted into the mouse VTA (orthotopic transplantation) or the nucleus accumbens (heterotopic transplantation), the grafted cells could accurately project to the target brain regions of endogenous A10 subtype dopaminergic neurons and specifically integrate into the host neural circuits. This result demonstrates that A10 dopaminergic neurons possess remarkable subtype specificity and precise neural circuit integration capabilities.

When chemogenetically engineered transplanted A10 dopaminergic neurons were activated by specific ligands, the host mice exhibited significant anti-anxiety and anti-depression phenotypes in behavioral experiments. This study is the first to demonstrate that transplantation of hPSC-derived A10 dopaminergic neuron subtypes can reconstruct this neural circuit and improve behavioral abnormalities in modeled mice, providing a novel approach for cell therapy in psychiatric disorders.

“This represents a milestone in the relatively unexplored field of cell therapy for mental illnesses. The study will initiate the clinical translation of using A10 dopaminergic neurons for depression at UniXell, which I believe will establish UniXell as a leading biotech in the field of cell therapy for psychiatric disorders,” said Dr. Chen.

About UniXell Biotechnology

Shanghai UniXell Biotechnology Co., Ltd. was established in 2021, focusing on cell therapy drug development for neurological diseases such as Parkinson’s disease and epilepsy. The company possesses a 4,000-square-meter R&D center and GMP facility, and has developed four innovative technology platforms based on reprogramming technology, stem cell differentiation technology, SISBAR lineage tracing technology, and high-precision gene editing. By 2025, the company has filed over 20 patent applications, with 4 granted utility model patents and 6 software copyrights. Its self-developed cell therapy drugs have received IND approvals from both China’s National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). Two subjects have successfully dosed, with postoperative data indicating good recovery.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

Futu Celebrates Its 14th Anniversary with “FUTU NEXT” Initiative Launch

Futu Celebrates Its 14th Anniversary with “FUTU NEXT” Initiative Launch

10 November 2026
STARFISH & KAPLAN COLLABORATE TO PROVIDE ACCESSIBLE EDUCATION PATHWAYS FOR YOUTHS

STARFISH & KAPLAN COLLABORATE TO PROVIDE ACCESSIBLE EDUCATION PATHWAYS FOR YOUTHS

10 November 2026
  • Trending
  • Comments
  • Latest

World Winter Sports Expo 2026 Opens, Charting a New Decade for Ice and Snow and Outdoor Industries

17 October 2026

Volant Aerotech Secures Firm Order from Sichuan Airlines Low Altitude for VE25-100 Passenger eVTOLs

19 October 2026

Volant Aerotech Secures Firm Order from Sichuan Airlines Low Altitude for VE25-100 Passenger eVTOLs

19 October 2026

Smart fire systems now a go at high-rise buildings

14 October 2026

Police to deploy facial recognition on CCTV networks

6 November 2026

Bournemouth stay perfect in Europa League

6 November 2026

Israeli fire kills five in Gaza, including a child

6 November 2026

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and Enrichment Strategy for HBV Functional Cure

6 November 2026

Recent News

Police to deploy facial recognition on CCTV networks

6 November 2026

Bournemouth stay perfect in Europa League

6 November 2026

Israeli fire kills five in Gaza, including a child

6 November 2026

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and Enrichment Strategy for HBV Functional Cure

6 November 2026
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com